Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Evaluation of the Impact of Elexacaftor/Tezacaftor/Ivacaftor on aerobic capacity in children with Cystic Fibrosis aged 6 to 11 years: Actual observations and clinical perspectives
Margarita Pérez-Ruiz; Mats te Bos; Patricia Fernández García; Cristina de Manuel Gómez; Ana Morales-Tirado; Alejandro López-Neyra; Marta Ruiz de Valbuena Maíz; Margarita Rubio; Verónica Sanz-Santiago;
10.1016/j.arbres.2025.02.010
Role of Systemic Inflammatory Indices in the Prediction of Moderate to Severe Bronchopulmonary Dysplasia in Preterm Infants
Ufuk Cakir; Cuneyt Tayman; Ali Ulas Tugcu; Duran Yildiz;
Arch Bronconeumol. 2023;59:216-22
Intravenous Iron Replacement Improves Exercise Tolerance in COPD: A Single-Blind Randomized Trial
Clara Martín-Ontiyuelo; Anna Rodó-Pin; Daniel Echeverría-Esnal; Mireia Admetlló; Xavier Duran-Jordà; Mariela Alvarado; Joaquim Gea; Esther Barreiro; Diego A. Rodríguez-Chiaradía;
Arch Bronconeumol. 2022;58:689-98